What is the recommended treatment for acute bacterial prostatitis in an otherwise healthy adult male?

Treatment for Acute Bacterial Prostatitis

For mild-to-moderate acute bacterial prostatitis in an otherwise healthy adult male, start ciprofloxacin 500–750 mg orally twice daily for 2–4 weeks if local fluoroquinolone resistance is below 10%; for severe cases requiring hospitalization, initiate ciprofloxacin 400 mg IV twice daily and transition to oral therapy once clinically improved. 1

---

Outpatient vs. Inpatient Decision

Hospitalization with IV antibiotics is mandatory for:

• Patients unable to tolerate oral medications 1
• Signs of systemic toxicity or risk of urosepsis (which occurs in 7.3% of cases) 1
• Inability to voluntarily urinate 2
• Suspected prostatic abscess 1

Outpatient oral therapy is appropriate for:

• Mild-to-moderate cases without fever who can tolerate oral intake 1, 2

---

First-Line Empiric Antibiotic Selection

Outpatient Oral Regimens

Fluoroquinolones remain first-line if local resistance is <10%: 1, 3

• Ciprofloxacin 500–750 mg orally twice daily for 2–4 weeks 1
• Avoid fluoroquinolones if local resistance exceeds 10% or if the patient received them in the last 6 months 1

Alternative oral agents when fluoroquinolones are contraindicated:

• Trimethoprim-sulfamethoxazole (TMP-SMX) only if the organism is known to be susceptible—do not use empirically due to high resistance rates 1, 3
• Doxycycline 100 mg orally every 12 hours for 7 days in men <35 years old to cover Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma species 1
• Fosfomycin has emerged as a useful repurposed agent for multidrug-resistant pathogens 3

Avoid empirically:

• Amoxicillin or ampicillin due to very high worldwide resistance rates 1
• Oral cephalosporins (e.g., cefpodoxime) have poor prostatic tissue penetration and are not recommended for prostatitis 1

Inpatient IV Regimens

For severe acute bacterial prostatitis requiring hospitalization:

• Ciprofloxacin 400 mg IV twice daily, transitioning to oral once clinically improved 1
• Piperacillin-tazobactam 4.5 g every 6–8 hours IV for broader coverage 4, 2
• Ceftriaxone plus doxycycline is a typical regimen for systemically ill patients 2

For healthcare-associated infections with suspected enterococci:

• Direct anti-enterococcal therapy with ampicillin, piperacillin-tazobactam, or vancomycin based on susceptibility 1

For multidrug-resistant organisms (e.g., ESBL-producing E. coli):

• Consider carbapenems: ertapenem 1 g once daily, meropenem 1 g every 8 hours IV, or imipenem-cilastatin 1 g every 6–8 hours IV 4
• Reserve carbapenems only when early culture results indicate multidrug resistance 1

---

Treatment Duration

Minimum 2–4 weeks of antibiotic therapy is required for acute bacterial prostatitis. 1, 3

• Assess clinical response after 48–72 hours of treatment 1
• Stopping antibiotics prematurely can lead to chronic bacterial prostatitis 1
• If symptoms improve, continue treatment for the full 2–4 weeks to achieve clinical cure and eradication of the pathogen 5

---

Diagnostic Workup

Essential diagnostic steps before or concurrent with empiric therapy:

• Midstream urine culture to identify the causative organism and guide antibiotic therapy 1
• Blood cultures in febrile patients 1
• Complete blood count to assess for leukocytosis 1
• Transrectal ultrasound if prostatic abscess is suspected 1, 4

Critical pitfall to avoid:

• Never perform prostatic massage or vigorous digital rectal examination in acute bacterial prostatitis due to risk of bacteremia and sepsis 1, 4
• Gentle digital rectal examination is acceptable to assess for a tender, enlarged, or boggy prostate 2

---

Causative Organisms

Gram-negative bacteria account for 80–97% of acute bacterial prostatitis cases:

• Escherichia coli is the most common pathogen 1
• Other gram-negatives include Klebsiella pneumoniae, Pseudomonas aeruginosa, Proteus mirabilis, Enterobacter species, and Serratia marcescens 1

Gram-positive bacteria (less common):

• Staphylococcus aureus, Enterococcus species, and Group B streptococci 1

Atypical pathogens in men <35 years old:

• Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma species require specific antimicrobial coverage with doxycycline or azithromycin 1

---

Special Considerations

Local resistance patterns should guide antibiotic selection:

• Fluoroquinolone resistance should ideally be <10% for empiric use 1
• Consider broader-spectrum options initially for patients with risk factors for antibiotic resistance or healthcare-associated infections 1

Adjust therapy based on culture results:

• Tailor antibiotics once urine or blood culture sensitivities are available 1, 2
• If no improvement after 48–72 hours, reassess and consider alternative diagnoses or resistant organisms 1

Prostatic abscess requires drainage:

• Antibiotics alone are insufficient—percutaneous drainage under transrectal ultrasound guidance is first-line 4
• Culture abscess fluid to confirm pathogen and antibiotic sensitivities 4

---

Common Pitfalls to Avoid

• Do not rely on antibiotics alone if prostatic abscess is present—drainage is mandatory for source control 4
• Do not use TMP-SMX or amoxicillin/ampicillin empirically due to high resistance rates 1
• Do not stop antibiotics prematurely—complete the full 2–4 week course to prevent chronic bacterial prostatitis 1
• Do not perform prostatic massage in acute prostatitis—this risks bacteremia 1, 4
• Do not use oral cephalosporins (e.g., cefpodoxime) for prostatitis due to poor prostatic tissue penetration 1

---

Follow-Up

• Reassess clinical response after 48–72 hours of treatment 1
• Evaluate for urinary retention or obstruction that may have predisposed to infection 4
• If symptoms persist or worsen, consider imaging (transrectal ultrasound) to rule out prostatic abscess 1, 4
• Ensure all sexual partners within the preceding 60 days are evaluated and treated if sexually transmitted pathogens are suspected 1